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Abstract
Endocrine disrupting chemicals (EDCs) are man-made compounds interfering with hormone signaling and thereby
adversely affecting human health. Recent reports provide evidence for the presence of EDCs in commercially available
bottled water, including steroid receptor agonists and antagonists. However, since these findings are based on biological
data the causative chemicals remain unidentified and, therefore, inaccessible for toxicological evaluation. Thus, the aim of
this study is to assess the antiestrogenic and antiandrogenic activity of bottled water and to identify the causative steroid
receptor antagonists. We evaluated the antiestrogenic and antiandrogenic activity of 18 bottled water products in reporter
gene assays for human estrogen receptor alpha and androgen receptor. Using nontarget high-resolution mass spectrometry
(LTQ-Orbitrap Velos), we acquired corresponding analytical data. We combined the biological and chemical information to
determine the exact mass of the tentative steroid receptor antagonist. Further MS
n experiments elucidated the molecule’s
structure and enabled its identification. We detected significant antiestrogenicity in 13 of 18 products. 16 samples were
antiandrogenic inhibiting the androgen receptor by up to 90%. Nontarget chemical analysis revealed that out of 24520
candidates present in bottled water one was consistently correlated with the antagonistic activity. By combining
experimental and in silico MS
n data we identified this compound as di(2-ethylhexyl) fumarate (DEHF). We confirmed the
identity and biological activity of DEHF and additional isomers of dioctyl fumarate and maleate using authentic standards.
Since DEHF is antiestrogenic but not antiandrogenic we conclude that additional, yet unidentified EDCs must contribute to
the antagonistic effect of bottled water. Applying a novel approach to combine biological and chemical analysis this is the
first study to identify so far unknown EDCs in bottled water. Notably, dioctyl fumarates and maleates have been overlooked
by science and regulation to date. This illustrates the need to identify novel toxicologically relevant compounds to establish
a more holistic picture of the human exposome.
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Introduction
By interfering with the organism’s complex hormone signaling
endocrine disrupting chemicals (EDCs) might adversely affect
development and reproduction [1,2]. Moreover, recent research
suggests an implication of EDCs in cancer, cardiovascular, and
metabolic disorders [3,4,5]. While research generates an ever-
growing list of potential EDCs, few compounds, namely Bisphenol
A (BPA) and phthalates, attract particular scientific attention and
public controversy. Used in a vast variety of consumer products,
these chemicals are ubiquitously detected in the environment as
well as in human samples [6,7,8]. With numerous studies
documenting adverse effects [9,10], public health concerns have
led to a voluntary or regulatory removal of BPA and phthalates in
some products (e.g., baby bottles, toys) and countries.
However, given the multitude of chemicals in use, these
measures might not resolve the problem. This is illustrated by a
recent study suggesting that plastic products marketed as BPA free
release significant amounts of estrogenic activity [11]. The authors
employed a sensitive in vitro bioassay to characterize the total
estrogenic burden leaching from plastics, including potential
mixture effects and unidentified EDCs. Using a similar approach,
a series of studies reported a widespread estrogenic contamination
of commercially available bottled water [12,13,14,15,16,17].
Another study adds to the picture by presenting new findings on
androgenic, antiandrogenic, progestagenic, and glucocorticoid-like
activity in bottled water [16]. Attempts to explain the observed
effects by targeted chemical analysis remained unsuccessful [18]
and it has soon become clear that ‘traditional’ EDCs are not
responsible for the endocrine activity in bottled water. Since the
causative chemical entity remains so far unidentified [19], the
findings are not easy to interpret in a toxicological context and,
consequently, prone to criticism [20].
Here, we combine biological and chemical analysis to identify
putative steroid receptor antagonists in bottled water. Most of the
products were potently antiestrogenic and antiandrogenic in the
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towards maleate and fumarate isomers as promising candidates
and subsequently enabled the identification of di(2-ethylhexyl)
fumarate. Because its concentration is too low to explain the
observed activity, other compounds must contribute. However,
further maleate/fumarate isomers are not only biologically active
but structurally highly similar to phthalates. Hence, we speculate
these compounds might represent a novel, so far overlooked group
of EDCs.
Methods
Reagents
All reagents used for sample preparation and bioassays have
been previously reported [17,21]. Reagents for chemical analysis
were the purest grade available. 2-Butenedioic acid (2Z)-, 1,4-
bis(2-ethylhexyl) ester (di(2-ethylhexyl) maleate, DEHM, CAS
142-16-5), 2-Butenedioic acid (2E)-, 1,4-bis(2-ethylhexyl) ester
(di(2-ethylhexyl) fumarate, DEHF, CAS 141-02-6), 2-Butenedioic
acid (2Z)-, 1,4-dioctyl ester (dioctyl maleate, DOM, CAS 2915-53-
9) were purchased from Sigma-Aldrich (Steinheim, Germany). 2-
Butenedioic acid (2E)-, 1,4-dioctyl ester (dioctyl fumarate, DOF,
CAS 2997-85-5) was purchased from Angene Intl. (Hong Kong,
PR China).
Samples and Sample Preparation
Samples and sample extraction procedures have been described
in detail previously [17]. In brief, 18 different bottled waters
(coded as samples 1–18) produced by 13 different companies in
France, Germany, and Italy were purchased in local supermarkets.
To optimize the extraction of steroid receptor antagonists, we
applied the same strategy as previously described [17]. First, one
brand of bottled water (sample 18) was extracted using six different
solid phase extraction (SPE) sorbents. Tap water extracted
identically served as procedural blank. In addition, empty SPE
cartridges were extracted to control for a potential contamination
of the materials. All extracts were analyzed for antiestrogenic
activity in the Yeast Antiestrogen Screen (see below). The extracts
of empty SPE cartridges and tap water did not induce significant
antiestrogenicity (Figure S1, S2). This indicates that neither
materials nor procedure cause a contamination of the samples.
An SPE method employing Isolute ENV+ cartridges (200 mg,
Biotage, Uppsala, Sweden) successfully extracted antiestrogenic
activity from bottled water (Figure S2).
Accordingly, this method was applied to the full sample set:
1.5 L of each sample was degassed and extracted with ENV+
cartridges. Samples were eluted with 4 mL methanol. 100 mL
DMSO was added as keeper. Methanol was removed under a
gentle stream of nitrogen yielding a final extract of 100 mL DMSO
(concentration factor 15,000). Identically treated tap water served
as procedural blank in all extractions. In addition, all used solvents
were concentrated like the extracts and analyzed for potential
contamination. The extraction was independently repeated three
times. All extracts were stored in glass vials with PTFE cap at
220uC prior to further analysis.
Bioassay
The antiestrogenic and antiandrogenic activity of bottled water
extracts was evaluated in reporter gene assays for human estrogen
receptor alpha (Yeast Antiestrogen Screen, YAES) and human
androgen receptor (Yeast Antiandrogen Screen, YAAS). To detect
antagonists, Yeast Estrogen Screen [22] and Yeast Androgen
Screen [23] were modified to analyze samples in the presence of
the endogenous ligand of each receptor (17b-estradiol, testoster-
one). Receptor antagonists present in the sample cause a
displacement of the endogenous ligand resulting in a decreased
reporter gene signal.
The general assay procedures have been described previously
[21,24]. Briefly, SPE extracts were diluted 480 fold in assay
medium and coincubated with 30 pM 17b-estradiol (YAES) or
2.5 nM testosterone (YAAS) dissolved in ethanol. Negative
controls, solvent controls (ethanol and DMSO) with and without
endogenous ligand, and positive controls (ligand coincubated with
a known receptor antagonist, YAES: 80 mM hydroxytamoxifen,
YAAS: 50 mM flutamide) were included in each experiment. The
maximum solvent concentration was 0.4% v/v in all cases.
Samples were analyzed in eight replicates, controls in 8–48
replicates. After 24 hours incubation at 30uC turbidity was read to
assess cytotoxicity and b-galactosidase activity was determined
[12]. Samples from three extractions were tested in three
independent YAES and YAAS experiments each.
To determine the relative inhibition of estrogen and androgen
receptor, the samples’ corrected absorbance (OD) determined in
each experiment was normalized to the adequate controls
containing the ligand 17b-estradiol or testosterone (ODC+E2/T,
0% inhibition) and without ligand (ODC-E2/T, 100% inhibition) as
follows: relative inhibition=100– ((ODsample-ODC-E2/T)/
(ODC+E2/T-ODC-E2/T) 6100). Inhibition data is reported as
means of three SPE extracts per sample analyzed in three
experiments (with eight replicates each) resulting in a sample size
of 63–72. The reported antagonistic activity corresponds to a
sample volume equivalent to 3.75 mL bottled water.
High-resolution Mass Spectrometry (LTQ-Orbitrap Velos)
For the chemical analysis 110 mL methanol was added to 40 mL
SPE extract. Samples from two independent extractions were
analyzed in two LC-ESI-LTQ-Orbitrap experiments. Chromato-
graphic conditions were the same as for quantification by LC-
tandem MS. The ESI source parameters for positive ionization
were set as follows: capillary temperature: 350uC; capillary voltage
3.5 kV; heater temperature 400uC; sheath gas flow rate 40
arbitrary units (AU); aux gas flow rate 15 AU; S-lens RF level
67%. Data dependent acquisition was used to conduct MS
2 and
MS
3 spectra as follows: a full scan (120–1200 m/z; positive mode)
was performed followed by MS
2 and MS
3 scans for the two most
intense ions with an intensity of .10,000 counts per second (cps)
and .1,000 cps, respectively. Collision induced dissociation (CID)
with a normalized collision energy of 35% was used for
fragmentation with an activation time of 10 ms. In addition,
dynamic exclusion was applied (exclusion of masses for which
three MS
n experiments have been performed; exclusion duration:
30 s) enabling also MS
n experiments for less abundant ions (e.g.,
during co-elution of different substances). Analysis using negative
ionization was performed at similar conditions (details not shown
here).
Chromatographic Conditions for Orbitrap and LC-
tandem MS Studies
Separations were performed using a Luna C18(2) column
(2 mm i.d., length 150 mm, particle size 3 mm) and a Secur-
ityGuard (both Phenomenex, Torrance, CA, USA) at 3062uC.
The flow rate was 0.2 mL/min. The HPLC gradient was
established by mixing two mobile phases. Phase A: MilliQ water
and phase B: methanol. Chromatographic separation was
achieved with the following gradient: 0–1 min: 0% B; 1–19 min:
0R100% B; 19–29 min: 100% B; 29–29.1 min: 100R0% B;
29.1–35 min: 0% B. 10 mL of each sample was injected.
Steroid Receptor Antagonists in Bottled Water
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Data
We used the open-source software MZmine 2.2 to process our
analytical data [25]. For each sample, a peak list was generated
applying the chromatogram builder and peak deconvolution
algorithms. For each LTQ-Orbitrap experiment, deisotoped peak
lists were aligned to match corresponding peaks in the multiple
samples. Finally, the peak finder algorithm was used to secondarily
identify peaks missed during peak detection.
Subsequently, these peak lists were filtered for peaks present in
at least twelve samples. To identify peaks coinciding with the
biological activity, we correlated the areas of each peak
(corresponding to its concentration) with the antiestrogenic and
antiandrogenic activity of the corresponding samples. From that,
we selected the peaks that correlated significantly with the
inhibition in the YAES and/or YAAS (p,0.05).
To further narrow down the number of candidates we
combined the peak lists of the two independent Orbitrap
experiments and filtered for peaks that were consistently detected
in both analytical runs with a maximum m/z difference of
10 ppm. Peaks with contradicting r-values in both experiments
were excluded as implausible. For the remaining candidates, we
checked the extracted ion chromatograms (XIC) and excluded
those, which were misinterpreted as peak by MZmine. For the
final candidates, we reanalyzed the exact masses (m/z), retention
times, and peak areas in the raw data (Xcalibur 2.1, Thermo
Fisher Scientific Inc., San Jose, USA). Scatter plots of the z-
transformed peak areas and the antiestrogenic and antiandrogenic
activity were used to assess the plausibility of correlation. This
procedure results in one remaining m/z candidate.
All statistical analysis was performed using Graphpad Prism
(5.03, GraphPad Software, Inc., San Diego, USA) and STATIS-
TICA (8.0, StatSoft, Inc., Tulsa, USA). Nonparametric Kruskal–
Wallis tests (with Dunn’s multiple comparison test) were applied to
compare bioassay data. A p value of ,0.05 was regarded as
significant.
Structural Elucidation and Identification
To gain information on the final candidate’s molecular structure
we conducted MS
n experiments: Samples with high concentra-
tions of the target compound (samples 13, 18) were analyzed using
the same experimental conditions as described above. The exact
mass of the final candidate (mean of all experiments and samples)
was searched in the ChemSpider database. Chemical structures
including possible adducts that matched the exact mass within a
range of 10 ppm were subjected to in silico fragmentation using
Mass Frontier 6.0 (HighChem, Ltd., Bratislava, Slovakia). The
experimental and predicted fragmentation spectra were com-
pared.
Confirmation
Chemicals with best matching fragmentation and plausible
structure (DEHM, DOM, DEHF, DOF) were purchased as
authentic standards. Their antiestrogenic and antiandrogenic
activity was evaluated in the bioassays (three experiments) as
described above in concentrations ranging from 300 nM to 1 mM
(in ethanol).
The HPLC system consisted of a G1367C autosampler, a
G1312B binary HPLC pump, a G1379B degasser (all Agilent
1200 SL Series, Waldbronn, Germany) and a MistraSwitch
column oven (MayLab Analytical Instruments, Wien, Austria).
The detection was performed on a API 4000 Qtrap mass
spectrometer (with turboionspray ionization, Applied Biosystems,
Foster City, CA, USA).
The tandem MS was operated in positive ion mode using
nitrogen as collision gas and multiple reaction monitoring (MRM)
for quantification. Parameters adjusted were collision gas (CAD), 6
mTorr; curtain gas (CUR), 20 psi; ion source gas 1 (GS1), 30 psi
and ion source gas 2 (GS2), 40 psi; source temperature (TEM),
500uC; entrance potential (EP), 10 V. The ionspray voltage (IS)
was adjusted to 5.5 kV and the interface heater (ihe) set on. Two
MRM transitions for each substance were monitored for
identification and quantification of the analytes. Parameters such
as declustering potential, collision energy, and cell exit potential
were optimized in the auto-tuning routine of the Analyst 1.4.2
software. Table S5 gives an overview of all MS parameters. For
chromatographic conditions see above.
Results
Optimizing Solid Phase Extraction
Using a similar approach as described previously [17] we
evaluated different SPE methods to isolate steroid receptor
antagonists from bottled water. Quality control experiments
indicate that neither the solvents nor the cartridges used for
extraction lead to a contamination of extracts with antiestrogens
(Figure S1). Likewise, tap water extracted as procedural blank
according to each method did not induce significant antiestrogenic
activity in the YAES (Figure S2). When comparing the extraction
efficiency, one SPE method (employing Isolute ENV+ cartridges)
yielded an extract that was significantly antiestrogenic. This
indicates that only the ENV+ sorbent (hydroxylated styrene-
divinylbenzene) was able to extract antiestrogens from bottled
water effectively (Figure S2).
Steroid Receptor Antagonists in Bottled Water
Extracted with the optimized method, the majority of bottled
water products significantly inhibited human estrogen as well as
androgen receptor. In the YAES 13 products were antiestrogenic
(Figure 1 A) with an inhibition of 19.2 (61.97) to 61.1 (62.09)%.
We detected significant antiandrogenic activity in 16 samples in
the YAAS (Figure 1 B). Here, antagonistic activity ranged from
19.0 (61.66) to 92.3 (60.88)%. The samples’ potential to
antagonize estrogen and androgen receptor is significantly
correlated (p,0.001, r=0.937, Figure S3). Tap water extracted
as blank did not induce any significant activity documenting that
the procedure does not lead to a contamination with antiestrogens
or antiandrogens.
Combining Nontarget Chemical Analysis and Bioassay
Data
We analyzed two distinct SPE extracts per sample in two
independent Orbitrap experiments using positive and negative
ionization. Following our data analysis strategy, initial data
processing with MZmine generated two lists with 15593 and
24520 peaks detected in the samples in the positive mode (Table
S1). These lists were restricted to peaks present in at least twelve
samples resulting in 12,466 and 18,685 peaks, respectively. We
then correlated the areas of these peaks with the antiestrogenic and
antiandrogenic activity and identified 938 and 1066 candidates
that were significantly correlated with the antagonistic activity in
the YAES and/or the YAAS (p,0.05). Out of these, 67 candidates
were detected in both Orbitrap experiments (Table S2). To further
narrow down this list we excluded candidates with inconsistent
correlations, i.e., correlation coefficients are positive in one and
negative in the other experiment. We assessed the extracted ion
Steroid Receptor Antagonists in Bottled Water
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only those with plausible chromatograms in both Orbitrap
experiments. Consequently, 40 peaks, which MZmine generated
from noise, were discarded.
From the raw data we manually reanalyzed the exact masses
(m/z), retention times, and peak areas of the three remaining
candidates (m/z 229.14103, 352.09008, and 363.25047). Corre-
lation of the recalculated peak areas with the biological activity
indicated that two candidates (229.14 and 325.09) were only
loosely and in some cases not significantly correlated in the
individual experiments (Figure S4). In addition, these candidates
correlated negatively with the antagonistic activity rendering them
biologically implausible. In contrast, the candidate with the mass
363.25 Da correlated positively with the antiestrogenic and
antiandrogenic activity consistently throughout all experiments
(p,0.05, see example in Figure 2). However, we identified three
samples that did not conform with this correlation: samples 7 and
11 as well as 8 and 11 induced potent antagonistic activity but the
mass 363.25 was detected in low concentrations in those samples
in LTQ-Orbitrap experiments 1 and 2, respectively. In general,
the correlation with antiandrogenicity was more pronounced than
with the antiestrogenic activity because bottled water inhibited
androgen receptor more potently (Figure S3 and S4).
Applying this data analysis strategy to the Orbitrap data
obtained in the negative mode resulted in peak lists with an initial
number of approximately 27,000–30,000 candidates. However,
filtering those lists according to the criteria described above did not
return valid candidates. Hence, data from negative ionization are
not presented here.
Structural Elucidation and Identification
Data dependent HR-tandem MS experiments and consecutive
HR-MS
3 studies consistently indicate that the parent ion (m/z of
363.25047) fragments into two daughter ions with a m/z of
251.1251 (ion 1) and 139.00004 (ion 2). The neutral loss from
parent to ion 1 and from ion 1 to 2 is m/z of 112.12506 and
112.12537, respectively. This corresponds to the loss of two C8H16
groups (Figure S5).
We then conducted a database search on ChemSpider to
identify plausible chemical structures matching the exact mass of
the parent ion. We downloaded all structures corresponding to the
possible adducts ([M+H]
+,[ M +K]
+,[ M +Na]
+,[ M +NH4]
+). Using
Mass Frontier for in silico fragmentation we were able to compare
the predicted and experimentally observed fragmentation patterns.
Defining a mass defect of 0.005 Da as cut-off, eight out of 483
unique chemical structures were predicted to produce fragments
matching the ones observed in the MS
n experiments (Table S3,
S4). These eight compounds are sodium adducts ([M+Na]
+) with a
corrected monoisotopic mass of 340.26136 and an empirical
formula of C20H36O4 (mass defect -0.00066 Da). All chemicals are
isomers of (2Z)- or (2E)-but-2-enedioate that differ in the structure
of their two octyl side chains (Table S4).
Confirmation
All isomers of but-2-enedioate possessing two octyl side chains
can be expected to conform to the fragmentation pattern observed
Figure 1. Antiestrogenic (A) and antiandrogenic activity (B) of 18 bottled waters. 13 waters significantly inhibit estrogen receptor alpha, 16
samples antagonize androgen receptor (wwwp,0.0001, compared to controls with endogenous ligand). The activity was normalized to controls
containing 17b-estradiol or testosterone (0% inhibition) and such without (100% inhibition). The results represent three extracts per sample tested in
three experiments with eight replicates each.
doi:10.1371/journal.pone.0072472.g001
Figure 2. Correlation of the peak areas (Z-transform) of the
final candidate (exact mass 363.25047) with the antiandro-
genicity. Data from Orbitrap experiment 1 is shown here exemplarily.
Triangles indicate outliers, the linear regression (with 95% confidence
bands) is shown in grey.
doi:10.1371/journal.pone.0072472.g002
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isomers (according to data availability in ChemSpider) and
analyzed authentic standards of the maleates DEHM and DOM
as well as the fumarates DEHF and DOF using the bioassays and
LC-tandem MS. The in vitro analysis confirmed that DEHF
(IC50=5.70610
24 M), DOM (IC50=1.07610
24 M), and DOF
(IC50=3.54610
25 M) are antiestrogenic in the YAES (Figure 3).
Moreover, DOM and DOF were antiandrogenic in the YAAS
(IC50=2.45610
24 and 1.58610
25 M, respectively). DEHM was
inactive in both bioassays (Figure 3 A).
In the LC-tandem MS (QqQ) analysis, all standards and
reanalyzed samples produced concordant SRMs (parent m/z
363.3, ion 1 m/z 251.2, ion 2 m/z 139.0) that were also in
accordance with the theoretical prediction (see Figure S6, S7).
Retention times (RT) were 27.78, 27.83, and 28.33 min for
DEHM, DEHF, and DOM, respectively. DOF was not analyzed.
Based on its structure, a longer retention compared to the other
isomers is most likely. The samples’ RT (27.88 min) best agrees
with the RT of DEHF (see Figure S6). Spiking a bottled water
sample with DEHF standard resulted in increased peaks at both
SRMs (data not shown). Therefore, chemical analysis confirms
with high probability that the molecule with the exact mass of m/z
363.25047 [M+Na]
+ is DEHF.
Discussion
Steroid Receptor Antagonists in Bottled Water
An increasing number of in vitro studies reports the presence of
EDCs in bottled water [12,13,14,15,17]. With previous studies
focusing on estrogenicity, the present work provides evidence for
an additional contamination with steroid receptor antagonists.
Using an optimized extraction procedure, we detected antiestro-
gens and antiandrogens in the majority of analyzed bottled water
products. Moreover, the antagonist activity was very potent. An
equivalent of 3.75 mL bottled water inhibited estrogen and
androgen receptor by up to 60 and 90%, respectively. By deriving
bio-equivalents [26], this inhibition can be set in relation to the
pharmaceutical antiandrogen flutamide that was used as reference
compound in the YAAS (Fig. S8). For the most active samples, the
inhibition corresponds to a theoretical concentration of 5.25 mg
flutamide equivalents L
21. In concordance with our findings,
Plotan et al. [16] recently reported antiandrogenicity in one third
of the analyzed bottled waters. Here, samples inhibited androgen
receptor by approximately 15–70% with the highest activity
detected in flavored products.
Similar to our previous study [17], an optimization of the
extraction procedure was necessary to isolate steroid receptor
antagonists from bottled water effectively. This demonstrates that
some commonly used sample preparation techniques are either
ineffective in extracting EDCs in quest or effective in coextracting
estrogens and antiestrogens that mask each other’s effects. Both
Figure 3. Antiestrogenic and antiandrogenic activity of DEHM (A), DEHF (B), DOM (C), and DOF (D). Data from three experiments with
eight replicates each. Dose-response relationships were generated using a four-parameter logistic function.
doi:10.1371/journal.pone.0072472.g003
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inability to detect endocrine activity in bottled water [18].
From a broader perspective, bottled water from six different
countries has been found to contain estrogenic [12,13,14,15,17],
antiestrogenic, and antiandrogenic (this study), as well as
androgenic, progestagenic, and glucocorticoid-like chemicals
[16]. This demonstrates that a popular beverage is contaminated
with diverse-acting EDCs. However, none of the causative
chemicals has been identified to date, hindering an evaluation of
the toxicological relevance of these findings.
Combining Nontarget Chemical Analysis and Bioassay
Data
To identify the chemical entity causing the antagonistic activity
of bottled water we combined analytical and biological data in a
novel approach. Traditionally, the effect-directed identification of
bioactive chemicals involves time-consuming fractionation of the
samples, identification of the active fraction(s) followed by
targeted, low-resolution mass spectrometry. Here, we instead
processed high-resolution mass spectrometry data to generate peak
lists containing all compounds detected in bottled water. We
assumed that the peak area of the putative receptor antagonist
must be correlated with the biological activity. This assumption is
only valid if one compound present in all samples is the major
driver of antagonistic activity. In our case, this is tentatively
supported by the excellent correlation of antiestrogenic and
antiandrogenic effects in all samples. Moreover, the latter clearly
implies that the same compound antagonizes both steroid
receptors.
Since approximately 1,000 of 25,000 peaks correlated with the
antagonistic activity, we applied consistency and plausibility
criteria to narrowed this list down to one final candidate. In that
step-wise procedure, the mandatory presence of a peak in two
extracts per sample and the reexamination of the peak shape
proved to be useful. In the end, a molecule with the monosisotopic
mass of m/z 363.25047 was consistently correlated with the
biological activity rendering it a promising candidate. A search in
the ChemSpider database returned 607 entries corresponding to
that mass. Hence, we fragmented these compounds in silico and
compared theoretical and experimentally observed fragmentation
patterns. Only sodium adducts of C20H36O4 with two octyl chains
(C6H6) produced concordant fragments. Therefore, we conclude
that the final candidate is an isomer of dioctyl maleate or
fumarate.
Identification and Confirmation
Using authentic standards of four common maleates and
fumarates we used chemical and biological analysis to confirm
the identity of the putative steroid receptor antagonist. LC-tandem
MS analysis confirmed with high probability that di(ethylhexyl)
fumarate (DEHF) is the isomer in quest. However, in the bioassays
DEHF was a weak antagonist of estrogen receptor, only. Albeit the
DEHF concentrations are correlated with the samples’ antiestro-
genicity, they are far too low (,250 ng L
21) to explain the
observed activity. Moreover, DEHF is inactive at androgen
receptor. Therefore, chemicals other than DEHF must contribute
to the antiestrogenicity and cause the antiandrogenicity we
detected in bottled water.
Because DEHF does not ultimately explain the observed
antagonistic activity, we need to critically review the limitations
of our analysis strategy. While the software-assisted generation of
nontargeted peak lists and in silico fragmentation proved suitable,
the core assumption of the correlation approach is only valid
under certain conditions. A compound will correlate with the
biological activity if it (a) is present in the majority of samples and
(b) is the only or at least the most superior driver of biological
activity. DEHF fulfills criterion (a) but misses (b) because of its low
antiestrogenicity and lacking antiandrogenicity. From that we can
deduce the following:
(i) The final candidate caused the activity but was misclassified
as DEHF. This means another isomer with the same exact
mass and retention time – probably also a maleate or
fumarate – is the active compound. Because of the multitude
of isomers (at least 15,842 isomers are theoretically possible)
this option is difficult to verify experimentally.
(ii) DEHF is correlated because it is the detectable proxy of
undetected, active compounds. This might be the case if
DEHF is part of a contaminant mixture introduced by the
same source (e.g., via the surfactant DEHSS, see below). If
other active components are present in that mixture but
remain undetected, DEHF would be nothing but a statistical
representation of these.
(iii) We observed a pseudocorrelation of DEHF and the
antagonistic activity. This implies that another undetected
compound caused the activity. Alternatively, we might also
be dealing with a mixture of steroid receptor antagonists.
These chemicals can be readily detected but will not
correlate with the activity because they are likely present in
different mixture ratios. The latter would also be the case if
each sample contains different antagonistic chemicals.
These issues cannot be resolved by data analysis alone but
demand alternative experimental approaches: The problem of
undetected chemicals requires the use of additional ionization
techniques during Orbitrap analysis (e.g., other ion sources). The
case of pseudocorrelation can only be explored by a physical
fractionation of the samples to deconvolute the effects of the
individual mixture constituents. However, although fractionation
reduces the number of analytes, it still yields fractions containing
numerous chemicals. For instance, when we fine-fractionated
leachates of polycarbonate bottles and analyzed the estrogenic
fractions in the Orbitrap, we still detected approximately 14,000
candidates (unpublished data). This illustrates that fractionation
alone does not resolve the problem. Thus, a combination of
physical fractionation and correlation-based data analysis appears
adequate to isolate EDCs from complex samples.
Maleates and Fumarates as Novel Group of Steroid
Receptor Antagonists
Keeping the limitations of this study in mind, it is, however,
possible that a C20H36O4 isomer other than DEHF is the causative
steroid receptor antagonist in bottled water. In principle, every
molecule with two octyl chains and a C4H2O4 center is a potential
candidate, including all, so far untested isomers of dioctyl maleate
and fumarate. In the bioassays, we found that unbranched
maleates/fumarates antagonized estrogen and androgen receptor,
albeit at high concentrations (DOM) or partially (DOF), only. This
provides first evidence for the assumption that dialkyl maleates/
fumarates might represent a novel group of steroid receptor
antagonists. However, future studies are needed to investigate the
potential toxicity of this chemical class more thoroughly. These
should include bioassays based on mammalian cells to support our
findings from yeast-based systems and account for potential
toxicokinetic and toxicodynamic differences.
Despite the dearth of published toxicological data, the structural
analogy of maleates and phthalates is striking (Fig. S9). Phthalates
are widely used plasticizers and well-documented steroid receptor
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the fumarates share a certain similarity with adipates (e.g., in the
octyl sidechains). Although far less well characterized with regard
to endocrine disrupting effects, adipates are promoted as substitute
to phthalates. Possessing a chemical structure similar to well-
known EDCs, dialkyl maleates and fumarates merit further
toxicological evaluation.
Sources of Maleates and Fumarates
Not much is known about the uses of dialkyl maleates and
fumarates.Hence,wecanonlyspeculateonitsorigininbottledwater.
DEHM, DEHF, and DOM have been proposed as alternative
plasticizers[28,29,30]buttheactualbreadthofapplicationisunclear.
Besidespolymers,thereareotherpotentialsources:Fiselieret al.[31]
detectedDEHMinmg–mgkg
21amountsinfoodstuff(rice,couscous,
noodles).Here,themaleatemigratedfromthecardboardpackaging
and was found to be an impurity of di(2-ethylhexyl) sulfosuccinate
(DEHSS),anemulsifierusedinwater-basedvarnishes.DEHSSisnot
only used in packaging coatings but serves as anionic surfactant in
other industrial applications. For instance, it is a component of
dispersantsusedduringtheDeepWaterHorizonoilspill[32]andan
authorizedwettingagentinbeveragesandfoodintheUS[33].Inour
study, we did not detect DEHSS in bottled water (data not shown).
However,sincemaleatesandfumaratesarepotentialimpuritiesand
degradationproductsofDEHSS(Fiselieret al.2010),thelattermay
be the original source of DEHFin bottledwater.
Conclusion
We have shown that antiestrogens and antiandrogens are
present in the majority of bottled water products. To identify the
causative chemical, we applied a novel correlation approach to
integrate biological and high-resolution mass spectrometry data.
Structural elucidation led to dioctyl maleate/fumarate isomers as
promising candidates. While chemical analysis confirmed that
DEHF is the putative steroid receptor antagonist, this compound
was weakly antiestrogenic in the bioassays, only. We conclude that
we have either missed active compound(s) or that another;
untested maleate/fumarate isomer causes the antagonistic activity
in bottled water. Two arguments support the latter: In addition to
DEHF other isomers were antiestrogenic and antiandrogenic.
Moreover, maleates are structurally highly similar to phthalate
plasticizers, well-known antiandrogens. Therefore, we pose the
hypothesis that dialkyl maleates and fumarates might represent a
novel group of steroid receptor antagonists. This illustrates that in
spite of the potentially relevant exposure and obvious resemblance
to other EDCs such chemicals have been so far disregarded by the
scientific and regulatory community. Therefore, we hope that our
findings will give fresh impetus to the effect-directed identification
of EDCs in beverages, foodstuff, and consumer products which, in
the end, will help providing a more holistic picture of human
exposure to EDCs.
Supporting Information
Figure S1 Antiestrogenic activity of the materials used
for the solid phase extraction in the YAES. The solvents
DMSO, acetone, and methanol (MeOH) and extracts of empty
cartridges (C18, Carb, ENV+, HLB, SDB
1, SDB
XC) did not
induce any significant antiestrogenicity. The antagonistic activity
was normalized to controls containing 17b-estradiol (C+E2, 0%
inhibition) and such without (C-E2, 100% inhibition).
(TIF)
Figure S2 Antiestrogenic activity of tap and bottled
water (sample 18) extracted with different SPE sorbents
(C18, Carb, ENV+, HLB, SDB
1, SDB
XC). The antagonistic
activity was normalized to controls containing 17b-estradiol
(C+E2, 0% inhibition) and such without (C-E2, 100% inhibition).
In the SPE of samples with neutral pH (A) only the ENV+ sorbent
was able to extract significant antiestrogenic activity from bottled
water (wp,0.05, compared to C+E2). Adjusting the pH of the
samples to 2 did not yield antiestrogenic extracts (B).
(TIF)
Figure S3 Correlation of the antiestrogenic and antian-
drogenic activity of bottled water.
(TIF)
Figure S4 Correlation of the peak areas (Z-transform)
of the three final candidates (m/z 229.14103, 352.09008,
and 363.25047) with the antagonistic activity in the YAES
and YAAS. Data sets from the sample extracts analyzed in
Orbitrap experiment 1 and 2 are shown here individually.
Triangles indicate outliers, the linear regression (with 95%
confidence bands) is shown in grey.
(TIF)
Figure S5 MS
2 (A) and MS
3 (B) fragmentation pattern of
the molecule with the exact mass of 363.25047 (in
sample 18).
(TIF)
Figure S6 Comparison of retention times and MRMs of
a sample and authentic standards.
(TIF)
Figure S7 Proposed fragmentation mechanism of but-2-
enedioate isomers, illustrated by the example of DOM.
(TIF)
Figure S8 Dose-response relationships of hydroxyta-
moxifen (A) and flutamide (B) used as reference
compounds in the YAES and YAAS, respectively. 95%
confidence bands are shown in grey.
(TIFF)
Figure S9 Structures of maleates (DOM, DEHM) and
fumarates (DOF, DEHF) compared to phthalates (di-n-
octyl phthalate, DOP; di(2-ethylhexyl) phthalate, DEHP)
and adipates (di-n-octyl adipate, DOA; di(2-ethylhexyl)
adipate, DEHA), respectively.
(TIF)
Table S1 Strategy for processing, combining, and
filtering the analytical and biological data to identify
candidates causing the antagonistic activity in bottled
water.
(DOCX)
Table S2 67 candidates detected in both Orbitrap
experiments correlated significantly with the antiestro-
genic and/or antiandrogenic activity in the YAES and
YAAS. Additionally, the evaluation of each candidate in the
following filtering procedure (plausibility of correlation, XIC and
scatter plots) is shown.
(DOCX)
Table S3 Database hits for different adducts of the
exact mass of 363.25047.
(DOCX)
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[M+Na]
+ and consistent in silico and experimental
fragmentation.
(DOCX)
Table S5 Parameters for confirmation studies via LC-
tandem MS.
(DOCX)
Text S1 Supporting text.
(DOCX)
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